Insider Selling: CME Group Inc (CME) COO Sells 3,353 Shares of Stock

CME Group Inc (NASDAQ:CME) COO Julie Holzrichter sold 3,353 shares of the stock in a transaction that occurred on Tuesday, November 6th. The shares were sold at an average price of $186.71, for a total value of $626,038.63. Following the transaction, the chief operating officer now owns 45,627 shares in the company, valued at approximately $8,519,017.17. The sale was disclosed in a document filed with the SEC, which is available through this link.

NASDAQ CME opened at $189.74 on Friday. CME Group Inc has a one year low of $137.51 and a one year high of $190.43. The company has a debt-to-equity ratio of 0.15, a current ratio of 1.09 and a quick ratio of 1.08. The firm has a market capitalization of $64.06 billion, a P/E ratio of 30.58, a PEG ratio of 2.19 and a beta of 0.49.

CME Group (NASDAQ:CME) last posted its quarterly earnings data on Thursday, October 25th. The financial services provider reported $1.45 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.42 by $0.03. CME Group had a return on equity of 9.18% and a net margin of 113.67%. The firm had revenue of $904.20 million during the quarter, compared to the consensus estimate of $910.50 million. On average, sell-side analysts forecast that CME Group Inc will post 6.64 earnings per share for the current year.

The business also recently announced a quarterly dividend, which will be paid on Thursday, December 27th. Shareholders of record on Monday, December 10th will be paid a $0.70 dividend. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.48%. The ex-dividend date of this dividend is Friday, December 7th. CME Group’s dividend payout ratio (DPR) is presently 58.70%.

A number of research analysts have recently issued reports on CME shares. Jefferies Financial Group reiterated a “buy” rating and set a $190.00 target price on shares of CME Group in a research report on Wednesday, September 5th. Zacks Investment Research downgraded CME Group from a “hold” rating to a “sell” rating in a research note on Wednesday, August 22nd. BidaskClub raised CME Group from a “hold” rating to a “buy” rating in a research note on Saturday, August 18th. Deutsche Bank reissued a “buy” rating and issued a $192.00 price objective (up from $185.00) on shares of CME Group in a research note on Thursday, October 11th. Finally, Rosenblatt Securities assumed coverage on CME Group in a research note on Wednesday, September 5th. They issued a “neutral” rating and a $177.00 price objective for the company. Five research analysts have rated the stock with a hold rating, nine have given a buy rating and one has issued a strong buy rating to the stock. CME Group currently has a consensus rating of “Buy” and a consensus target price of $182.69.

Several institutional investors and hedge funds have recently modified their holdings of CME. Meeder Asset Management Inc. increased its stake in shares of CME Group by 84.8% in the 2nd quarter. Meeder Asset Management Inc. now owns 789 shares of the financial services provider’s stock worth $129,000 after acquiring an additional 362 shares during the last quarter. Kaizen Advisory LLC increased its position in shares of CME Group by 151.9% during the 2nd quarter. Kaizen Advisory LLC now owns 816 shares of the financial services provider’s stock worth $134,000 after purchasing an additional 492 shares during the last quarter. Bbva Compass Bancshares Inc. acquired a new stake in shares of CME Group during the 3rd quarter worth about $134,000. Sun Life Financial INC increased its position in shares of CME Group by 267.7% during the 2nd quarter. Sun Life Financial INC now owns 923 shares of the financial services provider’s stock worth $151,000 after purchasing an additional 672 shares during the last quarter. Finally, Cornerstone Wealth Management LLC acquired a new stake in shares of CME Group during the 2nd quarter worth about $153,000. 84.28% of the stock is owned by institutional investors and hedge funds.

WARNING: “Insider Selling: CME Group Inc (CME) COO Sells 3,353 Shares of Stock” was first reported by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are accessing this news story on another publication, it was illegally copied and republished in violation of U.S. and international trademark & copyright laws. The original version of this news story can be read at https://www.dispatchtribunal.com/2018/11/10/insider-selling-cme-group-inc-cme-coo-sells-3353-shares-of-stock.html.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals.

Further Reading: Discover Your Risk Tolerance

Insider Buying and Selling by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.


Leave a Reply